<PAGE>
BD
FY 2000
Revenues by Business Segments and Major Product Groups
Quarter 4 Total Year
----------------------- --------------------
% Growth % Growth
----------------------- --------------------
Total US Int'l Total US Int'l
----------------------- --------------------
Medical
Injection System -0.7% -7.5% 5.6% 5.8% 4.6% 7.0%
Infusion Therapy Systems -5.1% -10.6% -1.5% 2.1% 10.6% -3.3%
Consumer Health Care -10.7% -16.0% 2.6% -1.5% -7.4% 9.3%
Pharmaceutical Systems 13.6% 39.6% 7.8% 7.1% 14.9% 5.5%
Other -5.1% -9.7% 0.1% -2.9% -2.6% -3.2%
----------------------- --------------------
-3.4% -10.0% 3.4% 2.2% 0.5% 3.7%
Preanalytical Solutions 2.2% 0.2% 4.7% 5.1% 4.4% 6.0%
Biosciences
Flow Cytometry 35.1% 44.7% 24.4% 36.3% 57.4% 15.7%
Microbiolgy 2.2% 0.5% 4.5% 2.7% 3.0% 2.4%
Labware 0.5% -3.3% 5.9% 6.2% 6.0% 6.4%
----------------------- --------------------
12.7% 13.5% 11.7% 13.4% 18.1% 7.5%
----------------------- --------------------
Total Company 1.9% -1.4% 5.8% 5.8% 6.6% 5.0%
======================= ====================
<PAGE>
BD
FY 2000
Revenues by Business Segments and Major Product Groups
($ in Millions)
Quarter 4 Total Year
----------------------- ----------------------
Amount Amount
----------------------- ----------------------
Total US Int'l Total US Int'l
----------------------- ----------------------
Medical
Injection System $153 $ 68 $ 84 $ 609 $ 295 $ 314
Infusion Therapy Systems 79 30 50 342 144 198
Consumer Health Care 143 96 47 505 307 198
Pharmaceutical Systems 66 15 51 255 48 207
Other 61 30 31 255 134 121
----------------------- ----------------------
502 239 263 1,966 927 1,039
Preanalytical Solutions 131 71 59 535 292 243
Biosciences
Flow Cytometry 113 64 49 407 232 175
Microbiolgy 137 78 59 568 332 236
Labware 37 21 16 143 81 62
----------------------- ----------------------
287 163 124 1,118 644 473
----------------------- ----------------------
Total Company $920 $474 $446 $3,618 $1,864 $1,755
======================= ======================
